{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:10:18Z","timestamp":1782969018285,"version":"3.54.5"},"reference-count":41,"publisher":"Society of Nuclear Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.2967\/jnumed.119.234906","type":"journal-article","created":{"date-parts":[[2019,12,14]],"date-time":"2019-12-14T02:45:13Z","timestamp":1576291513000},"page":"710-715","source":"Crossref","is-referenced-by-count":43,"title":["Histologically Confirmed Diagnostic Efficacy of <sup>18<\/sup>F-rhPSMA-7 PET for N-Staging of Patients with Primary High-Risk Prostate Cancer"],"prefix":"10.2967","volume":"61","author":[{"given":"Markus","family":"Kroenke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Wurzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Schwamborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Ulbrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Joo\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Rauscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Haller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Herz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-J\u00fcrgen","family":"Wester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang A.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Eiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2019,12,13]]},"reference":[{"key":"2021051712144688000_61.5.710.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21262"},{"key":"2021051712144688000_61.5.710.2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010101)91:1<66::AID-CNCR9>3.0.CO;2-P"},{"key":"2021051712144688000_61.5.710.3","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","article-title":"EAU-ESTRO-SIOG guidelines on prostate cancer: part 1\u2014screening, diagnosis, and local treatment with curative intent","volume":"71","author":"Mottet","year":"2017","journal-title":"Eur Urol"},{"key":"2021051712144688000_61.5.710.4","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200111000-00012"},{"key":"2021051712144688000_61.5.710.5","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/S0022-5347(17)36424-8","article-title":"The contemporary incidence of lymph node metastases in prostate cancer: implications for laparoscopic lymph node dissection","volume":"149","author":"Danella","year":"1993","journal-title":"J Urol."},{"key":"2021051712144688000_61.5.710.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(01)01441-8"},{"key":"2021051712144688000_61.5.710.7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0022-5347(17)38748-7","article-title":"Prognostic significance of lymph nodal metastases in prostate cancer","volume":"142","author":"Gervasi","year":"1989","journal-title":"J Urol."},{"key":"2021051712144688000_61.5.710.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(99)80219-2"},{"key":"2021051712144688000_61.5.710.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2009.03.012"},{"key":"2021051712144688000_61.5.710.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.11.008"},{"key":"2021051712144688000_61.5.710.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.09.039"},{"key":"2021051712144688000_61.5.710.12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00345-018-2182-1","article-title":"68Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) for primary staging of high-risk prostate cancer: a systematic review","volume":"36","author":"Corfield","year":"2018","journal-title":"World J Urol."},{"key":"2021051712144688000_61.5.710.13","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.eururo.2016.06.021","article-title":"Sensitivity, specificity, and predictors of positive 68Ga-prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analysis","volume":"70","author":"Perera","year":"2016","journal-title":"Eur Urol."},{"key":"2021051712144688000_61.5.710.14","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00259-016-3573-4","article-title":"F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients","volume":"44","author":"Giesel","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712144688000_61.5.710.15","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.234922"},{"key":"2021051712144688000_61.5.710.16","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.234609"},{"key":"2021051712144688000_61.5.710.17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.11.969"},{"key":"2021051712144688000_61.5.710.18","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-013-2445-4"},{"key":"2021051712144688000_61.5.710.19","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.154153"},{"key":"2021051712144688000_61.5.710.20","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.eururo.2013.02.007","article-title":"Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study","volume":"66","author":"Heck","year":"2014","journal-title":"Eur Urol."},{"key":"2021051712144688000_61.5.710.21","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.eururo.2011.12.009","article-title":"Diagnostic efficacy of [11C]choline positron emission tomography\/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy","volume":"61","author":"Maurer","year":"2012","journal-title":"Eur Urol."},{"key":"2021051712144688000_61.5.710.22","doi-asserted-by":"publisher","DOI":"10.2307\/2531595"},{"key":"2021051712144688000_61.5.710.23","doi-asserted-by":"publisher","DOI":"10.2307\/2533958"},{"key":"2021051712144688000_61.5.710.24","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780111108"},{"key":"2021051712144688000_61.5.710.25","doi-asserted-by":"publisher","DOI":"10.2307\/2531248"},{"key":"2021051712144688000_61.5.710.26","unstructured":"The R project for statistical computing. R website. https:\/\/www.R-project.org\/. Accessed January 8, 2020."},{"key":"2021051712144688000_61.5.710.27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-77"},{"key":"2021051712144688000_61.5.710.28","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v015.i02"},{"key":"2021051712144688000_61.5.710.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2007.05.022"},{"key":"2021051712144688000_61.5.710.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(98)00518-4"},{"key":"2021051712144688000_61.5.710.31","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70203-1"},{"key":"2021051712144688000_61.5.710.32","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-012-2069-0"},{"key":"2021051712144688000_61.5.710.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2015.12.025"},{"key":"2021051712144688000_61.5.710.34","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.219501"},{"key":"2021051712144688000_61.5.710.35","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.euf.2016.11.002","article-title":"68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography\/computed tomography for prostate cancer: a systematic review and meta-analysis","volume":"4","author":"von Eyben","year":"2018","journal-title":"Eur Urol Focus."},{"key":"2021051712144688000_61.5.710.36","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.juro.2017.07.070","article-title":"Prostate specific membrane antigen targeted 18F-DCFPyL positron emission tomography\/computerized tomography for the preoperative staging of high risk prostate cancer: results of a prospective, phase II, single center study","volume":"199","author":"Gorin","year":"2018","journal-title":"J Urol."},{"key":"2021051712144688000_61.5.710.37","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1097\/JU.0000000000000417","article-title":"68Ga-PSMA-11 positron emission tomography detects residual prostate cancer after prostatectomy in a multicenter retrospective study","volume":"202","author":"Farolfi","year":"2019","journal-title":"J Urol."},{"key":"2021051712144688000_61.5.710.38","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.eururo.2018.03.013","article-title":"99mTechnetium-based prostate-specific membrane antigen-radioguided surgery in recurrent prostate cancer","volume":"75","author":"Maurer","year":"2019","journal-title":"Eur Urol."},{"key":"2021051712144688000_61.5.710.39","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.7150\/thno.18421","article-title":"Diagnostic accuracy of Ga-68-HBED-CC-PSMA-ligand-PET\/CT before salvage lymph node dissection for recurrent prostate cancer","volume":"7","author":"Jilg","year":"2017","journal-title":"Theranostics."},{"key":"2021051712144688000_61.5.710.40","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.234914"},{"key":"2021051712144688000_61.5.710.41","first-page":"1174","article-title":"Positron ranges obtained from biomedically important positron-emitting radionuclides","volume":"16","author":"Cho","year":"1975","journal-title":"J Nucl Med."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.119.234906","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:47:56Z","timestamp":1621284476000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.119.234906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,13]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5,1]]},"published-print":{"date-parts":[[2020,5]]}},"alternative-id":["10.2967\/jnumed.119.234906"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.119.234906","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,13]]}}}